T&T Scientific University Leadership
Nima Tamaddoni, Ph.D.
Dr. Nima Tamaddoni, the Chief Executive Officer at T&T Scientific Corp., is a business executive and scientist who initiated and co-created T&T Scientific University. Nima has firm support for practical, applied, and cross border learning experience, research, and talents growth within a corporate environment. With this vision, the students get paid, educated with real-world application, skillful, and earn degrees (B.S., M.S., and Ph.D., M.D., etc.). He strongly believes that the future of academia and academic research must stem and be initiated from an applied need where the precious research, talents, and funds directly impact human and planet well-being. Nima has created this effort through the T&T Scientific University to build the world's first university where all research and eductions are conducted in a highly probable chance to be applied and an impactful environment. With this vision, we hope to maximize the transition of precious basic research to real-world application seamlessly with incredibly talented students and individuals who want to be scientists or earn any other degree and directly and positively impact the world. We are initiating this university within our field. We will broaden the areas step by step in several directions to make a global, applied, a unilingual university that all classes taken, and all lessons learned will be efficiently translated to an application. T&T Scientific University's goals are practical, applied, and full-filled at the front and center of basic research to direct all applications.
Dr. Tamaddoni has over ten years of academic, industrial, and business experience focused on lipid nanoparticles and liposomes. With leadership and engineering skills, knowledge, and training, he has successfully led the business growth and multiple pharmaceuticals research, development, and manufacturing projects at T&T Scientific Corporation. His goal at T&T Scientific is to help develop and improve technologies that increase the efficiency of translating promising medical technology from research and development to scaled-up pharmaceutical manufacturing for clinical trials and approved patient use. Nima's industry experience has been managing custom development and manufacturing non-viral delivery technologies for various pharmaceutical customers, and several projects have required working remotely and on-site with top-tier pharmaceutical companies. Since founding T&T Scientific, he has managed intra-company global business development projects to develop and improve tools that accelerate liposome and lipid nanoparticle-related and other non-viral vector research, development, and manufacturing. He helped lead the successful development and launch of multiple products in our NanoSizer product line, which provides scalable options for a cleaner, faster, and easier low-cost production of liposomes and lipid nanoparticles. Researchers and pharmaceutical manufacturers are using T&T NanoSizer devices in academia and industry in over 60 countries. We are expanding our product portfolio with a continuous solvent injection and exchange technology called NanoSizer FLOW. Twelve patents protect T&T Scientific technologies, and three trademarks protect T&T Scientific's brands.
Alex Aust, MS, MBA
Mr. Alex Aust, the Director of Business Development at T&T Scientific has strong talent, experience and knowledge of the industry that will bring you the true value from the project preparation, guidance, and proposal execution to completion of all deliverables for your drug products, whether it is in the discovery stage or commercial GMP manufacturing, and of course, anything in between. Alex has experience executing over 20 RNA technology transfers development and manufacturing projects with lipid-based formulations.
Alex Aust, the Director of Business Development, has vast experience in complex formulations, liquid injectables, and Lipid Nanoparticle (LNP) pharmaceutical manufacturing. His experience includes drug chemistry, analytics, manufacturing, and Controls (CMC), Business Development (BD), Supply Chain, Strategic Planning, Master Scheduling, Marketing, Quality Assurance, Validation Engineering, Quality Control, and Technical Writing as well as Regulatory in the pharmaceutical industry. Specifically, his background is in manufacturing nanoparticles and lipid-based drug delivery systems (lipid nanoparticles (LNP), liposomes, suspensions, etc.).
Alex joined T&T Scientific after spending about 10 years at a world-leading pharmaceutical liquid and complex drug injectable manufacturing. His experience and knowledge of the industry will bring you the true value from the project preparation, guidance, and proposal execution to completion of all deliverables for your drug products, whether it is in the discovery stage or commercial GMP manufacturing, and of course, anything in between.
Alex earned his M.B.A from Ball State University with a concentration on Manufacturing and Production Management. Previous to this, he obtained an M.S. from Purdue University while studying Molecular and Cellular Biology; his undergraduate studies were completed at the University of Southern Indiana; where he majored in Biology and minored in History.